Zoetis.com uses cookies to improve your experience when browsing our website. By continuing to use this site, you are agreeing to their use. To find out more, view our cookie policy.

One Health Approach

Animal and Human Health are Connected

We believe the development of sophisticated tools and technologies to protect companion animal health and to support livestock farming can have a significant positive impact on public health and the global supply of safe and affordable food.

  • Bioinformatics and biomarker development for diseases transcend species, uniting the disease understanding across the animal kingdom.
  • Solutions for newly emerging infectious diseases in animals help to protect the health of humans.
  • People and animals have a number of diseases in common, including osteoarthritis, kidney disease, allergic dermatitis and cardiovascular disease, just to name a few. Collaboration between human and animal health researchers provides the potential to advance the understanding of mutually relevant diseases and expand the translational approach to medicine. 
  • An abundant supply of safe, affordable animal proteins begins with healthy animals. Animal technologies that target control of infectious diseases, or that support the prediction or enhancement of feed efficiency in livestock, would be highly valuable to the animal health industry.
  • More than 60 percent of diseases that can affect people are zoonotic, meaning they can transmit between animals and people. Approaches to control infectious disease in animals, especially livestock, are becoming increasingly important.

Potential benefits of collaboration taking a One Health approach include:

  • Apply in vivo models to help accelerate pre-clinical research
  • Share compound libraries
  • Shorten cycle from research to commercialization by validating molecular targets in veterinary species natural disease
  • Open market opportunities and revenue streams in the near term from animal health uses of products
  • Utilize Zoetis expertise in veterinary biopharmaceuticals (monoclonal antibodies and protein therapeutics) to evaluate targets in non-rodent species

Please contact us if you would like to discuss an opportunity for collaboration or for more information about partnering with Zoetis.

Partnering with Zoetis